SARS-CoV-2 Antigen Rapid Qualitative Test Type B

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

PRL Rapid Quantitative Test (Chemiluminescence Immunoassay)

PRL Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Prolactin (PRL) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

2 in 1 (CEA/AFP) Rapid Quantitative Test

Biotime 2 in 1 (CEA/AFP) test kit has very important guiding significance in the diagnosis of liver cancer and can improve the accuracy of clinical diagnosis.

CCP Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime CCP Rapid Quantitative Test is intended to quantify the concentration of CCP in human serum, plasma and whole blood on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid detection of rheumatoid arthritis. -Fluorescence immunoassay -Rheumatoid arthritis For in vitro diagnostic use only. For professional use only.

CRP Rapid Quantitative Test (Chemiluminescence Immunoassay)

CRP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-reactive proteins (CRP) concentration in human serum, plasma and vein whole blood specimens.

FLI-4000 FIA Immunoassay Analyzer

FLI-4000 is an automatic immunoassay analyzer that measures the concentration of targeted analyte in human blood and urine. FLI-4000 is designed for processing / analyzing large volumes of samples and can carry up to 40 tests per hour (depending on the type of item).

HSV-1 IgG/IgM Rapid Test (Fluorescence Immunoassay)

The HSV-1 IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies to HSV1 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. HSV-1 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses 1 (HSV-1) infection -For in vitro diagnostic use only. For professional use only.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B